Chlorhydrate d'hydromorphone in Canada
86 medicine records from 15 holders carry this name in the official sources. Collected on November 16, 2026.
Medicines
| Name | Holder | Status | Code |
|---|---|---|---|
| APO-HYDROMORPHONE · 1 MG · TABLET | APOTEX INC | authorised |
DIN
02364115DPD drug code
84905
|
| APO-HYDROMORPHONE · 2 MG · TABLET | APOTEX INC | authorised |
DIN
02364123DPD drug code
84906
|
| APO-HYDROMORPHONE · 4 MG · TABLET | APOTEX INC | authorised |
DIN
02364131DPD drug code
84907
|
| APO-HYDROMORPHONE · 8 MG · TABLET | APOTEX INC | authorised |
DIN
02364158DPD drug code
84908
|
| APO-HYDROMORPHONE CR · 12 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02476657DPD drug code
96750
|
| APO-HYDROMORPHONE CR · 18 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02476665DPD drug code
96751
|
| APO-HYDROMORPHONE CR · 24 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02476673DPD drug code
96752
|
| APO-HYDROMORPHONE CR · 30 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02476681DPD drug code
96753
|
| APO-HYDROMORPHONE CR · 3 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02476614DPD drug code
96746
|
| APO-HYDROMORPHONE CR · 4.5 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02476622DPD drug code
96747
|
| APO-HYDROMORPHONE CR · 6 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02476630DPD drug code
96748
|
| APO-HYDROMORPHONE CR · 9 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02476649DPD drug code
96749
|
| BAR-HYDROMORPHONE CR · 12 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02460815DPD drug code
94830
|
| BAR-HYDROMORPHONE CR · 18 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02460823DPD drug code
94831
|
| BAR-HYDROMORPHONE CR · 24 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02460831DPD drug code
94832
|
| BAR-HYDROMORPHONE CR · 30 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02460858DPD drug code
94833
|
| BAR-HYDROMORPHONE CR · 3 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02460777DPD drug code
94826
|
| BAR-HYDROMORPHONE CR · 4.5 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02460785DPD drug code
94827
|
| BAR-HYDROMORPHONE CR · 6 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02460793DPD drug code
94828
|
| BAR-HYDROMORPHONE CR · 9 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02460807DPD drug code
94829
|
| DILAUDID · 1 MG per ML · LIQUID | PURDUE PHARMA | cancelled |
DIN
00786535DPD drug code
10173
|
| DILAUDID · 1 MG · TABLET | PURDUE PHARMA | authorised |
DIN
00705438DPD drug code
6889
|
| DILAUDID · 250 MG per VIAL · POWDER FOR SOLUTION | PURDUE PHARMA | cancelled |
DIN
02085895DPD drug code
16679
|
| DILAUDID · 2 MG per ML · LIQUID | PURDUE PHARMA | cancelled |
DIN
00627100DPD drug code
5937
|
| DILAUDID · 2 MG · TABLET | PURDUE PHARMA | authorised |
DIN
00125083DPD drug code
5939
|
| DILAUDID · 3 MG · SUPPOSITORY | PURDUE PHARMA | cancelled |
DIN
00125105DPD drug code
5938
|
| DILAUDID · 4 MG · TABLET | PURDUE PHARMA | authorised |
DIN
00125121DPD drug code
5940
|
| DILAUDID · 8 MG · TABLET | PURDUE PHARMA | authorised |
DIN
00786543DPD drug code
9509
|
| DILAUDID HP · 10 MG per ML · LIQUID | PURDUE PHARMA | cancelled |
DIN
00622133DPD drug code
5936
|
| DILAUDID-HP-PLUS · 20 MG per ML · SOLUTION | PURDUE PHARMA | cancelled |
DIN
02146118DPD drug code
17822
|
| DILAUDID-XP · 50 MG per ML · LIQUID | PURDUE PHARMA | cancelled |
DIN
02145863DPD drug code
17823
|
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 12MG · 12 MG · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02125366DPD drug code
20171
|
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG · 18 MG · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02243562DPD drug code
67480
|
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 24MG · 24 MG · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02125382DPD drug code
20172
|
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 30MG · 30 MG · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02125390DPD drug code
43838
|
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG · 3 MG · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02125323DPD drug code
18556
|
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG · 6 MG · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02125331DPD drug code
18558
|
| HYDROMORPH CONTIN · CONTROLLED-RELEASE CAPSULE · 4.5 MG · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02359502DPD drug code
84452
|
| HYDROMORPH CONTIN · CONTROLLED-RELEASE CAPSULE · 9 MG · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02359510DPD drug code
84453
|
| HYDROMORPH.IR - 2MG · 2 MG · TABLET | PURDUE PHARMA | cancelled |
DIN
02245703DPD drug code
69806
|
| HYDROMORPH.IR - 4MG · 4 MG · TABLET | PURDUE PHARMA | cancelled |
DIN
02245704DPD drug code
69807
|
| HYDROMORPH.IR - 8MG · 8 MG · TABLET | PURDUE PHARMA | cancelled |
DIN
02245705DPD drug code
69808
|
| HYDROMORPHONE · 1 MG · TABLET | SORRES PHARMA INC | cancelled |
DIN
02192101DPD drug code
35655
|
| HYDROMORPHONE · 2 MG · TABLET | SORRES PHARMA INC | cancelled |
DIN
02249928DPD drug code
73474
|
| HYDROMORPHONE · 4 MG · TABLET | SORRES PHARMA INC | cancelled |
DIN
02249936DPD drug code
73475
|
| HYDROMORPHONE · 8 MG · TABLET | SORRES PHARMA INC | cancelled |
DIN
02192144DPD drug code
35658
|
| HYDROMORPHONE HCL TAB 2MG USP · 2 MG · TABLET | ROXANE LABS, DIVISION OF BOEHRINGER INGELHEIM | cancelled |
DIN
01916289DPD drug code
12596
|
| HYDROMORPHONE HCL TAB 4MG USP · 4 MG · TABLET | ROXANE LABS, DIVISION OF BOEHRINGER INGELHEIM | cancelled |
DIN
01916270DPD drug code
12595
|
| HYDROMORPHONE HP 10 · 10 MG per ML · SOLUTION | SANDOZ CANADA INCORPORATED | authorised |
DIN
02145928DPD drug code
18323
|
| HYDROMORPHONE HP 20 · 20 MG per ML · SOLUTION | SANDOZ CANADA INCORPORATED | authorised |
DIN
02145936DPD drug code
18325
|
Need this list in your own system?
Every record on this page is available through the API, with its source, licence and retrieval date.